Indian generic drug maker Lupin Ltd. (500257.BY) Thursday said it has settled a patent infringement litigation with Santarus Inc. (SNTS) and DepoMed Inc. (DEPO) over the Glumetza extended-release tablets for diabetes treatment.
Lupin Settles Patent Dispute Over Glumetza Diabetes Treatment
February 23, 2012 |
Permalink
Warning: Trying to access array offset on value of type bool in /var/www/html/diabetesnews.com/wp-content/themes/dn_default/single.php on line 20
Tweet
Warning: Trying to access array offset on value of type bool in /var/www/html/diabetesnews.com/wp-content/themes/dn_default/single.php on line 20
Tweet
Posted in Other News